BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 37402856)

  • 41. COVID-19 alters human microbiomes: a meta-analysis.
    Reuben RC; Beugnon R; Jurburg SD
    Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
    Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
    Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome.
    Liu Q; Mak JWY; Su Q; Yeoh YK; Lui GC; Ng SSS; Zhang F; Li AYL; Lu W; Hui DS; Chan PK; Chan FKL; Ng SC
    Gut; 2022 Mar; 71(3):544-552. PubMed ID: 35082169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coronavirus disease-2019 and the intestinal tract: An overview.
    Alberca GGF; Solis-Castro RL; Solis-Castro ME; Alberca RW
    World J Gastroenterol; 2021 Apr; 27(13):1255-1266. PubMed ID: 33833480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut microbiota and Covid-19- possible link and implications.
    Dhar D; Mohanty A
    Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gut Microbiome Alterations in COVID-19.
    Zuo T; Wu X; Wen W; Lan P
    Genomics Proteomics Bioinformatics; 2021 Oct; 19(5):679-688. PubMed ID: 34560321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19 associated EBV reactivation and effects of ganciclovir treatment.
    Meng M; Zhang S; Dong X; Sun W; Deng Y; Li W; Li R; Annane D; Wu Z; Chen D
    Immun Inflamm Dis; 2022 Apr; 10(4):e597. PubMed ID: 35349757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
    Zuo T; Zhan H; Zhang F; Liu Q; Tso EYK; Lui GCY; Chen N; Li A; Lu W; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Oct; 159(4):1302-1310.e5. PubMed ID: 32598884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review.
    Bellucci G; Albanese A; Rizzi C; Rinaldi V; Salvetti M; Ristori G
    Front Immunol; 2023; 14():1161849. PubMed ID: 37334371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful Treatment of SARS-CoV-2 Vaccination-related Activation of Rheumatoid Arthritis with Positive Findings for Epstein-Barr Virus.
    Nakamura H; Nagasawa Y; Kobayashi H; Tsukamoto M; Takayama T; Kitamura N
    Intern Med; 2022 Jul; 61(13):2073-2076. PubMed ID: 35466171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low perforin expression in CD8+ T lymphocytes during the acute phase of severe SARS-CoV-2 infection predicts long COVID.
    Kundura L; Cezar R; André S; Campos-Mora M; Lozano C; Vincent T; Muller L; Lefrant JY; Roger C; Claret PG; Duvnjak S; Loubet P; Sotto A; Tran TA; Estaquier J; Corbeau P
    Front Immunol; 2022; 13():1029006. PubMed ID: 36341327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 Complications in a Newly Diagnosed HIV Patient: A Case of Multiple Herpesvirus Reactivation and HLH Post-ART Initiation.
    Davari S; Taunk PS; Madaline T
    Am J Case Rep; 2023 Jul; 24():e939847. PubMed ID: 37452490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection.
    Trottein F; Sokol H
    Cell Rep; 2020 Jul; 32(3):107915. PubMed ID: 32649864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Traditional Chinese medicine against COVID-19: Role of the gut microbiota.
    Yang Z; Liu Y; Wang L; Lin S; Dai X; Yan H; Ge Z; Ren Q; Wang H; Zhu F; Wang S
    Biomed Pharmacother; 2022 May; 149():112787. PubMed ID: 35279010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut microbiota in COVID-19: new insights from inside.
    Zhou B; Pang X; Wu J; Liu T; Wang B; Cao H
    Gut Microbes; 2023; 15(1):2201157. PubMed ID: 37078497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic active Epstein-Barr virus infection with reinfection of SARS-CoV-2: a case report.
    Wu H; Liu L; Qu J; Wang C; Shi X; Lei Y
    Virol J; 2024 Jun; 21(1):142. PubMed ID: 38910238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients.
    Crunfli F; Carregari VC; Veras FP; Silva LS; Nogueira MH; Antunes ASLM; Vendramini PH; Valença AGF; Brandão-Teles C; Zuccoli GDS; Reis-de-Oliveira G; Silva-Costa LC; Saia-Cereda VM; Smith BJ; Codo AC; de Souza GF; Muraro SP; Parise PL; Toledo-Teixeira DA; Santos de Castro ÍM; Melo BM; Almeida GM; Firmino EMS; Paiva IM; Silva BMS; Guimarães RM; Mendes ND; Ludwig RL; Ruiz GP; Knittel TL; Davanzo GG; Gerhardt JA; Rodrigues PB; Forato J; Amorim MR; Brunetti NS; Martini MC; Benatti MN; Batah SS; Siyuan L; João RB; Aventurato ÍK; Rabelo de Brito M; Mendes MJ; da Costa BA; Alvim MKM; da Silva Júnior JR; Damião LL; de Sousa IMP; da Rocha ED; Gonçalves SM; Lopes da Silva LH; Bettini V; Campos BM; Ludwig G; Tavares LA; Pontelli MC; Viana RMM; Martins RB; Vieira AS; Alves-Filho JC; Arruda E; Podolsky-Gondim GG; Santos MV; Neder L; Damasio A; Rehen S; Vinolo MAR; Munhoz CD; Louzada-Junior P; Oliveira RD; Cunha FQ; Nakaya HI; Mauad T; Duarte-Neto AN; Ferraz da Silva LF; Dolhnikoff M; Saldiva PHN; Farias AS; Cendes F; Moraes-Vieira PMM; Fabro AT; Sebollela A; Proença-Modena JL; Yasuda CL; Mori MA; Cunha TM; Martins-de-Souza D
    Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2200960119. PubMed ID: 35951647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic.
    Hu J; Zhang L; Lin W; Tang W; Chan FKL; Ng SC
    Trends Food Sci Technol; 2021 Feb; 108():187-196. PubMed ID: 33519087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of the microbiota-gut-brain axis in postacute COVID syndrome.
    Gareau MG; Barrett KE
    Am J Physiol Gastrointest Liver Physiol; 2023 Apr; 324(4):G322-G328. PubMed ID: 36880667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Long Road of Long COVID: Specific Considerations for the Allergist/Immunologist.
    Bellanti JA; Novak P; Faitelson Y; Bernstein JA; Castells MC
    J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3335-3345. PubMed ID: 37774781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.